Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization.
作者:
主题词
多发性骨髓瘤(Multiple Myeloma);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);小鼠(Mice);淋巴细胞活化(Lymphocyte Activation);T淋巴细胞(T-Lymphocytes);单链抗体(Single-Chain Antibodies);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.3389/fimmu.2024.1389018
PMID
38720898
发布时间
2024-05-10
- 浏览0
Frontiers in immunology
1389018页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文